Literature DB >> 16475017

Neuroendocrine and behavioural responses to CO2 inhalation in central versus peripheral autonomic failure.

Joey M Kaye1, Tim M Young, Christopher J Mathias, Laura Watson, Stafford L Lightman.   

Abstract

Multiple system atrophy (MSA) and pure autonomic failure (PAF) represent distinct pathological models of autonomic failure in humans. We have investigated the neuroendocrine, behavioural and autonomic cardiovascular responses to the 35% CO2 challenge. Nine patients with MSA, nine with PAF and five control subjects received a single breath of 35% CO2. Peripheral autonomic failure (i.e., PAF) was associated with significantly lower resting noradrenaline levels. All groups demonstrated a significant pressor response to CO2. In controls, the mean pressor response was +60.2 mm Hg, which was significantly smaller in both the PAF (+26.8 mm Hg, P < 0.01) and MSA (+18.3 mm Hg, P < 0.001) patients. In addition, the onset of the response was significantly delayed in both MSA (140.2 s) and PAF (154.2 s) patients compared with controls (32.4 s, P = 0.04 and P = 0.03, respectively). Noradrenaline levels increased only in controls. Central autonomic impairment (i.e., MSA) was associated with lower cortisol release (+8.8% in MSA compared with +35.2% in control and +23.7% in PAF) and fewer somatic symptoms of emotional arousal. Both MSA and PAF exhibit marked sympathetic autonomic impairment, however, residual (albeit differing) sympathetic pathways can still maintain a partial cardiovascular response. A central autonomic lesion, however, also appears to be associated with blunting of both cortisol and emotional responses to this stress paradigm.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16475017     DOI: 10.1007/s10286-006-0331-x

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  32 in total

1.  Mechanisms of CO2 challenges.

Authors:  E Griez; K Schruers
Journal:  J Psychopharmacol       Date:  2003-09       Impact factor: 4.153

2.  Central activation of the sympatheticoadrenal system by hypoxia and hypercapnia.

Authors:  B A CROSS; I A SILVER
Journal:  J Endocrinol       Date:  1962-03       Impact factor: 4.286

3.  Effect of carbon dioxide inhalation on arterial pressure, ECG and plasma catecholamines and 17-OH corticosteroids in normal man.

Authors:  P H SECHZER; L D EGBERT; H W LINDE; D Y COOPER; R D DRIPPS; H L PRICE
Journal:  J Appl Physiol       Date:  1960-05       Impact factor: 3.531

4.  Sympathetically mediated hypertension in autonomic failure.

Authors:  J R Shannon; J Jordan; A Diedrich; B Pohar; B K Black; D Robertson; I Biaggioni
Journal:  Circulation       Date:  2000-06-13       Impact factor: 29.690

5.  Stimulation of sympathetic activity by carbon dioxide in patients with autonomic failure compared to normal subjects.

Authors:  S Braune; A Hetzel; A Prasse; K Dohms; B Guschlbauer; C H Lücking
Journal:  Clin Auton Res       Date:  1997-12       Impact factor: 4.435

6.  A new test for autonomic cardiovascular and neuroendocrine responses in diabetes mellitus: evidence for early vagal dysfunction.

Authors:  J M Kaye; R J Corrall; S L Lightman
Journal:  Diabetologia       Date:  2004-12-29       Impact factor: 10.122

7.  Sympathetic neural outflow directly recorded in patients with primary autonomic failure: clinical observations, microneurography, and histopathology.

Authors:  R Dotson; J Ochoa; P Marchettini; M Cline
Journal:  Neurology       Date:  1990-07       Impact factor: 9.910

8.  Carbon dioxide/oxygen challenge test in panic disorder.

Authors:  G Perna; M Battaglia; A Garberi; C Arancio; A Bertani; L Bellodi
Journal:  Psychiatry Res       Date:  1994-05       Impact factor: 3.222

9.  Inhalation of 35% CO(2) results in activation of the HPA axis in healthy volunteers.

Authors:  Spilios V Argyropoulos; Jayne E Bailey; Sean D Hood; Adrian H Kendrick; Ann S Rich; Gabriel Laszlo; Jon R Nash; Stafford L Lightman; David J Nutt
Journal:  Psychoneuroendocrinology       Date:  2002-08       Impact factor: 4.905

10.  35% CO2 challenge in panic and mood disorders.

Authors:  G Perna; B Barbini; S Cocchi; A Bertani; M Gasperini
Journal:  J Affect Disord       Date:  1995-03-14       Impact factor: 4.839

View more
  3 in total

1.  Autonomic and cognitive dysfunction in Parkinson's disease.

Authors:  Juan Idiaquez; Eduardo E Benarroch; Hugo Rosales; Pablo Milla; Lily Ríos
Journal:  Clin Auton Res       Date:  2007-03-27       Impact factor: 4.435

2.  Clinical characteristics of latent classes of CO2 hypersensitivity in adolescents and young adults.

Authors:  Lance M Rappaport; Christina Sheerin; Jeanne E Savage; John M Hettema; Roxann Roberson-Nay
Journal:  Behav Res Ther       Date:  2017-03-30

3.  Abnormal cardiovascular sympathetic and parasympathetic responses to physical and emotional stimuli in depersonalization disorder.

Authors:  Andrew P Owens; Anthony S David; David A Low; Christopher J Mathias; Mauricio Sierra-Siegert
Journal:  Front Neurosci       Date:  2015-03-26       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.